The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 18, Issue 4, Pages 319-329
Publisher
Informa UK Limited
Online
2018-03-05
DOI
10.1080/14737159.2018.1448269
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases
- (2017) Eileen Samy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
- (2016) Y.-T. Tai et al. BLOOD
- Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma
- (2016) E. Sanchez et al. CLINICAL CANCER RESEARCH
- Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
- (2016) Michael Ghermezi et al. HAEMATOLOGICA
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
- (2016) S Hipp et al. LEUKEMIA
- Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
- (2016) Michael Ghermezi et al. HAEMATOLOGICA
- An Anti-B Cell Maturation Antigen Bispecific Antibody for Multiple Myeloma
- (2015) Nitya S. Ramadoss et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- γ-secretase directly sheds the survival receptor BCMA from plasma cells
- (2015) Sarah A. Laurent et al. Nature Communications
- Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
- (2014) Y.-T. Tai et al. BLOOD
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma
- (2014) E Kastritis et al. LEUKEMIA
- B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
- (2013) R. O. Carpenter et al. CLINICAL CANCER RESEARCH
- Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival
- (2012) Eric Sanchez et al. BRITISH JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now